5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.78▼ | 6.80▼ | 6.81▼ | 6.51▲ | 5.20▲ |
MA10 | 6.79▼ | 6.81▼ | 6.84▼ | 6.13▲ | 4.58▲ |
MA20 | 6.79▼ | 6.87▼ | 6.75▼ | 5.30▲ | 4.44▲ |
MA50 | 6.82▼ | 6.69▲ | 6.26▲ | 4.56▲ | 5.79▲ |
MA100 | 6.87▼ | 6.23▲ | 5.73▲ | 4.47▲ | 7.70▼ |
MA200 | 6.73▲ | 5.62▲ | 4.88▲ | 5.48▲ | 10.30▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.031▼ | -0.038▼ | 0.149▲ | 0.364▲ |
RSI | 38.745▼ | 47.384▼ | 56.228▲ | 75.694▲ | 64.942▲ |
STOCH | 50.382 | 16.442▼ | 21.242 | 78.722 | 73.612 |
WILL %R | -87.500▼ | -98.000▼ | -59.756 | -17.857▲ | -12.531▲ |
CCI | -198.957▼ | -105.083▼ | -71.345 | 135.257▲ | 239.419▲ |
Thursday, July 25, 2024 07:41 AM
Anavex Life Sciences (AVXL), Peakstone Realty Trust (PKST), AC ... SAN FRANCISCO, December 14, 2023--Getaround (NYSE: GETR), the world's first connected carsharing marketplace, today announced ...
|
Wednesday, July 24, 2024 12:59 PM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
|
Tuesday, July 23, 2024 10:56 PM
Cassava Sciences' claims about simufilam for Alzheimer's disease are under scrutiny and unlikely to be approved by the FDA. Read an update on SAVA here.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/07/24 | 7.00 | 7.24 | 6.715 | 6.74 | 1,367,485 |
25/07/24 | 6.50 | 7.09 | 6.39 | 6.84 | 1,473,635 |
24/07/24 | 6.53 | 6.78 | 6.39 | 6.46 | 1,405,072 |
23/07/24 | 5.88 | 6.82 | 5.85 | 6.58 | 2,178,443 |
22/07/24 | 5.66 | 5.94 | 5.50 | 5.91 | 1,037,548 |
19/07/24 | 5.71 | 5.79 | 5.47 | 5.48 | 692,310 |
18/07/24 | 5.93 | 6.09 | 5.655 | 5.70 | 887,545 |
17/07/24 | 5.70 | 5.98 | 5.58 | 5.92 | 923,072 |
16/07/24 | 5.95 | 6.15 | 5.71 | 5.83 | 1,698,615 |
15/07/24 | 5.39 | 5.88 | 5.39 | 5.83 | 1,332,098 |
|
|
||||
|
|
||||
|
|